Effect of reduced cholinergic transmission by rocuronium on the hypoxic ventilatory response in patients with obstructive sleep apnea - before and after three months of continous positive airway pressure treatment. A non-radomised, non-blinded study.
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2012
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Sleep apnoea syndrome
- Focus Pharmacodynamics
- 05 Mar 2012 New trial record